Profile: Auris Medical Holding Ltd (EARS.OQ)
Auris Medical Holding Ltd. is a clinical stage biopharmaceutical company. The Company is engaged in developing therapeutics for the neurotology and mental health supportive care.
The Company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201). In addition the Company has two Phase 3 programs under development: Sonsuvi (AM-111) for acute inner ear hearing loss and Keyzilen (AM-101) for acute inner ear tinnitus.
Auris Medical Holding Ltd
ZUG ZUG 6300